• Login
    • Library Home
    View Item 
    •   BracU IR
    • Brac Business School (BBS)
    • Internship Report, BBA (Brac Business School)
    • View Item
    •   BracU IR
    • Brac Business School (BBS)
    • Internship Report, BBA (Brac Business School)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Financial analysis of GlaxoSmithKline Bangladesh Ltd.: a guideline for potential shareholders

    Thumbnail
    View/Open
    14304019_BBA.pdf (808.7Kb)
    Date
    2018-04-05
    Author
    Saeem, Abu Shalah Md. Shake
    Metadata
    Show full item record
    URI
    http://hdl.handle.net/10361/10096
    Abstract
    GlaxoSmithKline first established in Bangladesh on the year 1949 and used to import it’s own product through Chittagong port. As time went by, GSK started to establish its own manufacturing unit in Chittagong as they found the cheap labor and easy resources of Bangladesh lucrative. So, it has been more than 67 years that GSK has been operating in Bangladesh and it’s really providing excellent service in Consumer Healthcare and Pharmaceutical sector. As a leading multinational company they are offering high quality medicines and vaccines to enhance the quality of human life around the world. GlaxoSmithKline has a strong Marketing and Trade Finance department which is working in line with the strategies of the organization and working with the aim of attaining the mission and vision of the company. GlaxoSmithKline Bangladesh Ltd is listed in the Dhaka Stock Exchange and has been performing quite good in the share market. GlaxoSmithKline Bangladesh Limited has a very high dividend payout ratio that mainly attracts the shareholders of the company. The profitability of this company has decreased in the year 2016. The company has a very lower current ratio that could pose a threat for it. So the company should increase its focus on this matter and should be careful to control the debts. Although, after comparing GSK’s financial report with Beximco Pharmaceutical’s and Reckitt Benckiser’s, it has been found that GSK has been doing good financially. It should be working on expanding its product line as it has a narrow product line and also should work on improving its current ratio. Shareholders would be highly benefited if the company could increase its Earning per share ratio. In order to perform better, GSK should be more focused on expanding its product line and its payout ratio.
    Keywords
    GlaxoSmithKline Bangladesh Limited; GSK
     
    Description
    This internship report is submitted in a partial fulfillment of the requirements for the degree of Bachelor of Business Administration, 2018.
     
    Cataloged from PDF version of internship report.
     
    Includes bibliographical references (page 37).
    Department
    BRAC Business School, BRAC University
    Collections
    • Internship Report, BBA (Brac Business School)

    Copyright © 2008-2019 Ayesha Abed Library, Brac University 
    Contact Us | Send Feedback
     

     

    Policy Guidelines

    • BracU Policy
    • Publisher Policy

    Browse

    All of BracU Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Copyright © 2008-2019 Ayesha Abed Library, Brac University 
    Contact Us | Send Feedback